Literature DB >> 17296492

Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition.

Matthew Cave1, Ion Deaciuc, Christian Mendez, Zhenyuan Song, Swati Joshi-Barve, Shirish Barve, Craig McClain.   

Abstract

More than 20% of Americans have nonalcoholic fatty liver disease (NAFLD), and this is, by far, the leading cause of abnormal liver enzymes in the United States. Nonalcoholic steatohepatitis (NASH), a more serious form of NAFLD, can proceed to cirrhosis and even hepatocellular carcinoma. These liver diseases represent the hepatic component of the metabolic syndrome, and this spectrum of liver disease represents a major health problem both in the United States and worldwide. Hepatic steatosis is closely linked to nutrition, including obesity, possibly high-fructose corn syrup consumption and consumption of certain types of fats. There are a variety of second insults or "hits" that appear to transform simple steatosis into NASH, with some of these second hits including certain proinflammatory cytokines, oxidative stress and possibly industrial toxins. In certain underdeveloped countries, it appears likely that industrial toxins play a role in NASH, and there is increasing interest in the potential interaction of industrial toxins and nutrients. Moreover, optimal therapy for NAFLD appears to include lifestyle modification with exercise, diet and weight loss. Certain nutrients may also be of benefit. Important areas for future research are the effect(s) of nutritional supplements on NAFLD/NASH and the effects of industrial toxins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17296492     DOI: 10.1016/j.jnutbio.2006.12.006

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  81 in total

Review 1.  Nutrition and nonalcoholic fatty liver disease in children.

Authors:  Miriam B Vos; Craig J McClain
Journal:  Curr Gastroenterol Rep       Date:  2008-06

2.  Long-Term, Fructose-Induced Metabolic Syndrome-Like Condition Is Associated with Higher Metabolism, Reduced Synaptic Plasticity and Cognitive Impairment in Octodon degus.

Authors:  Daniela S Rivera; Carolina B Lindsay; Juan F Codocedo; Laura E Carreño; Daniel Cabrera; Marco A Arrese; Carlos P Vio; Francisco Bozinovic; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2018-04-13       Impact factor: 5.590

3.  Nutrition and nonalcoholic fatty liver disease in children.

Authors:  Miriam B Vos; Craig J McClain
Journal:  Curr Diab Rep       Date:  2008-10       Impact factor: 4.810

4.  Metabolomic analysis of the effects of chronic arsenic exposure in a mouse model of diet-induced Fatty liver disease.

Authors:  Xiang Zhang; Walter H Watson; Xue Shi; Xiaoli Wei; Imhoi Koo; Robin H Schmidt; Xinmin Yin; Seong Ho Kim; Andrew Vaughn; Craig J McClain; Gavin E Arteel
Journal:  J Proteome Res       Date:  2013-12-17       Impact factor: 4.466

5.  Role of dietary fatty acids in liver injury caused by vinyl chloride metabolites in mice.

Authors:  Lisanne C Anders; Heegook Yeo; Brenna R Kaelin; Anna L Lang; Adrienne M Bushau; Amanda N Douglas; Matt Cave; Gavin E Arteel; Craig J McClain; Juliane I Beier
Journal:  Toxicol Appl Pharmacol       Date:  2016-09-28       Impact factor: 4.219

6.  Toxicant-associated steatohepatitis in vinyl chloride workers.

Authors:  Matt Cave; Keith Cameron Falkner; Mukunda Ray; Swati Joshi-Barve; Guy Brock; Rehan Khan; Marjorie Bon Homme; Craig J McClain
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

7.  Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice.

Authors:  Banrida Wahlang; K Cameron Falkner; Bonnie Gregory; Douglas Ansert; David Young; Daniel J Conklin; Aruni Bhatnagar; Craig J McClain; Matt Cave
Journal:  J Nutr Biochem       Date:  2013-04-22       Impact factor: 6.048

8.  Antisocial behavioral syndromes and past-year physical health among adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Risë B Goldstein; Deborah A Dawson; S Patricia Chou; W June Ruan; Tulshi D Saha; Roger P Pickering; Frederick S Stinson; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2008-03       Impact factor: 4.384

9.  Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(-/-) mouse: implications for a "multihit" hypothesis of fatty liver disease.

Authors:  Shannon M Bailey; Sudheer K Mantena; Telisha Millender-Swain; Yavuz Cakir; Nirag C Jhala; David Chhieng; Kent E Pinkerton; Scott W Ballinger
Journal:  Free Radic Biol Med       Date:  2009-04-01       Impact factor: 7.376

10.  Effect of CAR activation on selected metabolic pathways in normal and hyperlipidemic mouse livers.

Authors:  Tadeja Rezen; Viola Tamasi; Anita Lövgren-Sandblom; Ingemar Björkhem; Urs A Meyer; Damjana Rozman
Journal:  BMC Genomics       Date:  2009-08-19       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.